Abstract: A molded contact lens comprising a stiffer optic zone relative to the peripheral zone of the contact lens provides an optical element for correcting astigmatism without the need for or substantially minimizing the need for the correction of rotational misalignment. The higher elastic modulus optic zone vaults over the cornea thereby allowing a tear lens to form. The tear lens follows or assumes the shape of the back surface of the contact lens. The combination of the tear lens and the optical zone provide an optical element for correction of refractive error.
Abstract: Described are silicone hydrogels that are more biocompatible than current ocular materials. The silicone hydrogels are formed from a reactive monomer mixture comprising: a mixture of hydroxyl substituted silicone containing components, at least one polyamide; and at least one hydrophilic monomer. The silicone hydrogels also display a desirable balance of properties, including clarity, oxygen permeability, wettability and desirable protein uptake.
Abstract: Described is a silicone hydrogel contact lens having non-uniform morphology. The contact lens may be made from a reactive mixture comprising: a silicone-containing component; a hydrophilic component; a non-reactive polymeric internal wetting agent; and a polymerization initiator, the contact lens having an oxygen permeability of at least about 60 barrers, and wherein the molar ratio in the lens of the polymeric non-reactive internal wetting agent to silicone, without a surface treatment, is greater in the lens's surface than in its bulk.
Type:
Grant
Filed:
December 13, 2022
Date of Patent:
November 28, 2023
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Azaam Alli, Donald E. Riederer, Alexander Guzman, Bernardo Santa Maria
Abstract: Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a
Type:
Grant
Filed:
April 28, 2021
Date of Patent:
November 21, 2023
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Brian Aitken, Charles Scales, Scott Joslin, Yong Zhang, Dola Sinha, Shivkumar Mahadevan, Patricia Martin, Fang Lu, Donnie Duis, Stephen C. Arnold
Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
Type:
Grant
Filed:
March 21, 2022
Date of Patent:
November 21, 2023
Assignees:
Guangzhou Bioseal Co., Ltd., Johnson & Johnson China Ltd., Ethicon, Inc.
Abstract: Provided are compounds described by the Formula I: wherein: R1 is a linear or branched, saturated or unsaturated aliphatic group having from 5 to 22 carbon atoms; R2 is selected from the group consisting of the functional groups: —NH2; and salts thereof; n is from 0 to 4; and R3 is a linear or branched, saturated or unsaturated aliphatic group having from 1 to 6 carbon atoms. Also provided are compositions comprising, and methods of use of, the compounds of the present invention.
Type:
Grant
Filed:
June 3, 2021
Date of Patent:
November 21, 2023
Assignee:
Johnson & Johnson Consumer Inc.
Inventors:
Robert J. Gambogi, Anthony R. Geonnotti, III, Michael C. Giano, Latrisha Petersen
Abstract: Described herein are systems and/or methods for forming an ophthalmic lens. An example method may comprise a step of determining a power profile based on a power profile function defined by a base optical power, an amount of spherical aberration at a radial distance from a geometric center of the lens, and a bump function. The example method may comprise a step of adjusting the power profile based at least on minimizing a shape metric of a through-focus curve.
Type:
Grant
Filed:
September 28, 2020
Date of Patent:
November 21, 2023
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Xin Wei, Philippe F Jubin, Derek Nankivil, Minghan Chen, Gregory Williby
Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
Abstract: In one embodiment, an irrigated medical system includes a medical tool, an irrigation line configured to fluidically connect an irrigation reservoir storing irrigation fluid to the medical tool, and provide at least some of the irrigation fluid to the medical tool, a force sensor configured to be coupled with the irrigation reservoir, and provide a signal responsively to a force exerted by the irrigation reservoir on the force sensor over time as irrigation fluid in the irrigation reservoir is depleted, and a controller configured to find an irrigation rate of the irrigation fluid flowing in the irrigation line responsively to the signal.
Abstract: An ocular surgical apparatus is provided, including a processor configured to receive ocular surgical data and a graphical user interface configured to display the ocular surgical data to a user. The processor configured to filter the ocular surgical data and the graphical user interface configured to display filtered ocular surgical data. The processor is configured to receive a number of ocular surgical data samples, discard selected ocular surgical data samples thereby yielding a number of emphasized samples, and perform an operation on the number of emphasized samples to produce filtered ocular surgical data.
Type:
Grant
Filed:
April 8, 2021
Date of Patent:
November 7, 2023
Assignee:
Johnson & Johnson Surgical Vision, Inc.
Inventors:
Abraham Hajishah, Mitchell W. Mallough, Joseph E. Pedroza